Viral Vector and Vaccine - Global and China Top Players Market Share and Ranking 2023
According to Latest Study, the global market for Viral Vector and Vaccine should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Viral Vector and Vaccine market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Viral Vector and Vaccine market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Research Institutes grew percent to account for percent of the total market sales, and Biopharmaceutical Companies grew percent.
This report studies and analyses global Viral Vector and Vaccine status and future trends, helps the client to determine the Viral Vector and Vaccine market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Viral Vector and Vaccine, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Viral Vector and Vaccine market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global Viral Vector and Vaccine sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China Viral Vector and Vaccine sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global Viral Vector and Vaccine key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Viral Vector and Vaccine key producing regions, capacity, production, and year over year growth
(6) Viral Vector and Vaccine industry chains, upstream, midstream and downstream
Market segment by players, this report covers
ABL
Addgene
Aldevron
Boehringer Ingelheim International GmbH
Brammer Bio
Charles River Laboratories
Creative-Biogene
Fujifilm Corporation
General Electric
MerckKGaA
Novasep
Pfizer
Spark Therapeutics
Thermo Fisher Scientific
Waisman Biomanufacturing
Market segment by Type, covers
Adenovirus
Fowlpox Virus
Attenuated Yellow Fever
Vaccinia Virus Vectors
Market segment by Application, can be divided into
Research Institutes
Biopharmaceutical Companies
Others
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Viral Vector and Vaccine product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Viral Vector and Vaccine market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Viral Vector and Vaccine market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Viral Vector and Vaccine, percent & CAGR, 2018-2029
Chapter 5: Viral Vector and Vaccine industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Viral Vector and Vaccine Definition
1.2 Global Viral Vector and Vaccine Market Size and Forecast
1.2.1 By Consumption Value, Global Viral Vector and Vaccine Market Size，2018-2029
1.2.2 By Sales Quantity, Global Viral Vector and Vaccine Market Size，2018-2029
1.2.3 Global Viral Vector and Vaccine Average Selling Price (ASP)，2018-2029
1.3 China Viral Vector and Vaccine Market Size and Forecast
1.3.1 By Consumption Value, China Viral Vector and Vaccine Market Size，2018-2029
1.3.2 By Sales Quantity, China Viral Vector and Vaccine Market Size，2018-2029
1.3.3 China Viral Vector and Vaccine Average Selling Price (ASP)， 2018-2029
1.4 Share of China Viral Vector and Vaccine Market with Respect to the Global Market
1.4.1 By Consumption Value, China Viral Vector and Vaccine Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Viral Vector and Vaccine Market Share in Global, 2018-2029
1.4.3 Viral Vector and Vaccine Market Size: China VS Global, 2018-2029
1.5 Viral Vector and Vaccine Market Dynamics
1.5.1 Viral Vector and Vaccine Market Drivers
1.5.2 Viral Vector and Vaccine Market Restraints
1.5.3 Viral Vector and Vaccine Industry Trends
1.5.4 Viral Vector and Vaccine Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Viral Vector and Vaccine, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Viral Vector and Vaccine, Global Market Share by Company, 2018-2023
2.3 Viral Vector and Vaccine Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Viral Vector and Vaccine Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Viral Vector and Vaccine Concentration Ratio
2.6 Global Viral Vector and Vaccine Mergers & Acquisitions, Expansion Plans
2.7 Global Viral Vector and Vaccine Manufacturers Product Type
2.8 Head Office and Viral Vector and Vaccine Production Site of Key Manufacturer
2.9 Viral Vector and Vaccine Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Viral Vector and Vaccine, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Viral Vector and Vaccine, China Market Share by Company, 2018-2023
3.3 China Viral Vector and Vaccine Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Viral Vector and Vaccine Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Viral Vector and Vaccine Capacity by Region
4.3 Global Viral Vector and Vaccine Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Viral Vector and Vaccine Production by Region, 2018-2029
4.5 Global Viral Vector and Vaccine Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Viral Vector and Vaccine Industry Chain
5.2 Viral Vector and Vaccine Upstream Analysis
5.2.1 Viral Vector and Vaccine Core Raw Materials
5.2.2 Main Manufacturers of Viral Vector and Vaccine Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Viral Vector and Vaccine Production Mode
5.6 Viral Vector and Vaccine Procurement Model
5.7 Viral Vector and Vaccine Industry Sales Model and Sales Channels
5.7.1 Viral Vector and Vaccine Sales Model
5.7.2 Viral Vector and Vaccine Typical Distributors
6 Sights by Type
6.1 Viral Vector and Vaccine Classification
6.1.1 Adenovirus
6.1.2 Fowlpox Virus
6.1.3 Attenuated Yellow Fever
6.1.4 Vaccinia Virus Vectors
6.2 By Type, Global Viral Vector and Vaccine Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Viral Vector and Vaccine Consumption Value, 2018-2029
6.4 By Type, Global Viral Vector and Vaccine Sales Quantity, 2018-2029
6.5 By Type, Global Viral Vector and Vaccine Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Viral Vector and Vaccine Segment by Application
7.1.1 Research Institutes
7.1.2 Biopharmaceutical Companies
7.1.3 Others
7.2 By Application, Global Viral Vector and Vaccine Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Viral Vector and Vaccine Consumption Value, 2018-2029
7.4 By Application, Global Viral Vector and Vaccine Sales Quantity, 2018-2029
7.5 By Application, Global Viral Vector and Vaccine Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Viral Vector and Vaccine Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Viral Vector and Vaccine Consumption Value, 2018-2029
8.3 By Region, Global Viral Vector and Vaccine Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Viral Vector and Vaccine & Forecasts, 2018-2029
8.4.2 By Country, North America Viral Vector and Vaccine Market Size Market Share
8.5 Europe
8.5.1 Europe Viral Vector and Vaccine Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Viral Vector and Vaccine Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Viral Vector and Vaccine Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Viral Vector and Vaccine Market Size Market Share
8.7 South America
8.7.1 South America Viral Vector and Vaccine Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Viral Vector and Vaccine Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Viral Vector and Vaccine Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Viral Vector and Vaccine Consumption Value, 2018-2029
9.3 By Country, Global Viral Vector and Vaccine Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Viral Vector and Vaccine Market Size, 2018-2029
9.4.2 By Type, U.S. Viral Vector and Vaccine Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Viral Vector and Vaccine Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Viral Vector and Vaccine Market Size, 2018-2029
9.5.2 By Type, Europe Viral Vector and Vaccine Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Viral Vector and Vaccine Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Viral Vector and Vaccine Market Size, 2018-2029
9.6.2 By Type, China Viral Vector and Vaccine Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Viral Vector and Vaccine Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Viral Vector and Vaccine Market Size, 2018-2029
9.7.2 By Type, Japan Viral Vector and Vaccine Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Viral Vector and Vaccine Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Viral Vector and Vaccine Market Size, 2018-2029
9.8.2 By Type, South Korea Viral Vector and Vaccine Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Viral Vector and Vaccine Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Viral Vector and Vaccine Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Viral Vector and Vaccine Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Viral Vector and Vaccine Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Viral Vector and Vaccine Market Size, 2018-2029
9.10.2 By Type, India Viral Vector and Vaccine Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Viral Vector and Vaccine Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Viral Vector and Vaccine Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Viral Vector and Vaccine Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Viral Vector and Vaccine Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 ABL
10.1.1 ABL Company Information, Head Office, Market Area, and Industry Position
10.1.2 ABL Viral Vector and Vaccine Models, Specifications, and Application
10.1.3 ABL Viral Vector and Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 ABL Company Profile and Main Business
10.1.5 ABL Recent Developments
10.2 Addgene
10.2.1 Addgene Company Information, Head Office, Market Area, and Industry Position
10.2.2 Addgene Viral Vector and Vaccine Models, Specifications, and Application
10.2.3 Addgene Viral Vector and Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Addgene Company Profile and Main Business
10.2.5 Addgene Recent Developments
10.3 Aldevron
10.3.1 Aldevron Company Information, Head Office, Market Area, and Industry Position
10.3.2 Aldevron Viral Vector and Vaccine Models, Specifications, and Application
10.3.3 Aldevron Viral Vector and Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Aldevron Company Profile and Main Business
10.3.5 Aldevron Recent Developments
10.4 Boehringer Ingelheim International GmbH
10.4.1 Boehringer Ingelheim International GmbH Company Information, Head Office, Market Area, and Industry Position
10.4.2 Boehringer Ingelheim International GmbH Viral Vector and Vaccine Models, Specifications, and Application
10.4.3 Boehringer Ingelheim International GmbH Viral Vector and Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Boehringer Ingelheim International GmbH Company Profile and Main Business
10.4.5 Boehringer Ingelheim International GmbH Recent Developments
10.5 Brammer Bio
10.5.1 Brammer Bio Company Information, Head Office, Market Area, and Industry Position
10.5.2 Brammer Bio Viral Vector and Vaccine Models, Specifications, and Application
10.5.3 Brammer Bio Viral Vector and Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Brammer Bio Company Profile and Main Business
10.5.5 Brammer Bio Recent Developments
10.6 Charles River Laboratories
10.6.1 Charles River Laboratories Company Information, Head Office, Market Area, and Industry Position
10.6.2 Charles River Laboratories Viral Vector and Vaccine Models, Specifications, and Application
10.6.3 Charles River Laboratories Viral Vector and Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Charles River Laboratories Company Profile and Main Business
10.6.5 Charles River Laboratories Recent Developments
10.7 Creative-Biogene
10.7.1 Creative-Biogene Company Information, Head Office, Market Area, and Industry Position
10.7.2 Creative-Biogene Viral Vector and Vaccine Models, Specifications, and Application
10.7.3 Creative-Biogene Viral Vector and Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Creative-Biogene Company Profile and Main Business
10.7.5 Creative-Biogene Recent Developments
10.8 Fujifilm Corporation
10.8.1 Fujifilm Corporation Company Information, Head Office, Market Area, and Industry Position
10.8.2 Fujifilm Corporation Viral Vector and Vaccine Models, Specifications, and Application
10.8.3 Fujifilm Corporation Viral Vector and Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Fujifilm Corporation Company Profile and Main Business
10.8.5 Fujifilm Corporation Recent Developments
10.9 General Electric
10.9.1 General Electric Company Information, Head Office, Market Area, and Industry Position
10.9.2 General Electric Viral Vector and Vaccine Models, Specifications, and Application
10.9.3 General Electric Viral Vector and Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 General Electric Company Profile and Main Business
10.9.5 General Electric Recent Developments
10.10 MerckKGaA
10.10.1 MerckKGaA Company Information, Head Office, Market Area, and Industry Position
10.10.2 MerckKGaA Viral Vector and Vaccine Models, Specifications, and Application
10.10.3 MerckKGaA Viral Vector and Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 MerckKGaA Company Profile and Main Business
10.10.5 MerckKGaA Recent Developments
10.11 Novasep
10.11.1 Novasep Company Information, Head Office, Market Area, and Industry Position
10.11.2 Novasep Viral Vector and Vaccine Models, Specifications, and Application
10.11.3 Novasep Viral Vector and Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Novasep Company Profile and Main Business
10.11.5 Novasep Recent Developments
10.12 Pfizer
10.12.1 Pfizer Company Information, Head Office, Market Area, and Industry Position
10.12.2 Pfizer Viral Vector and Vaccine Models, Specifications, and Application
10.12.3 Pfizer Viral Vector and Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Pfizer Company Profile and Main Business
10.12.5 Pfizer Recent Developments
10.13 Spark Therapeutics
10.13.1 Spark Therapeutics Company Information, Head Office, Market Area, and Industry Position
10.13.2 Spark Therapeutics Viral Vector and Vaccine Models, Specifications, and Application
10.13.3 Spark Therapeutics Viral Vector and Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Spark Therapeutics Company Profile and Main Business
10.13.5 Spark Therapeutics Recent Developments
10.14 Thermo Fisher Scientific
10.14.1 Thermo Fisher Scientific Company Information, Head Office, Market Area, and Industry Position
10.14.2 Thermo Fisher Scientific Viral Vector and Vaccine Models, Specifications, and Application
10.14.3 Thermo Fisher Scientific Viral Vector and Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Thermo Fisher Scientific Company Profile and Main Business
10.14.5 Thermo Fisher Scientific Recent Developments
10.15 Waisman Biomanufacturing
10.15.1 Waisman Biomanufacturing Company Information, Head Office, Market Area, and Industry Position
10.15.2 Waisman Biomanufacturing Viral Vector and Vaccine Models, Specifications, and Application
10.15.3 Waisman Biomanufacturing Viral Vector and Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.15.4 Waisman Biomanufacturing Company Profile and Main Business
10.15.5 Waisman Biomanufacturing Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Viral Vector and Vaccine Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Viral Vector and Vaccine Market Restraints
Table 3. Viral Vector and Vaccine Market Trends
Table 4. Viral Vector and Vaccine Industry Policy
Table 5. Global Viral Vector and Vaccine Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Viral Vector and Vaccine Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Viral Vector and Vaccine Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Viral Vector and Vaccine Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Viral Vector and Vaccine Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Viral Vector and Vaccine Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Viral Vector and Vaccine Mergers & Acquisitions, Expansion Plans
Table 12. Global Viral Vector and Vaccine Manufacturers Product Type
Table 13. Head Office and Viral Vector and Vaccine Production Site of Key Manufacturer
Table 14. Viral Vector and Vaccine Capacity of Major Manufacturers and Future Plan
Table 15. China Viral Vector and Vaccine Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Viral Vector and Vaccine Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Viral Vector and Vaccine Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Viral Vector and Vaccine Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Viral Vector and Vaccine Production by Region, 2018-2023, (K Units)
Table 20. Global Viral Vector and Vaccine Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Viral Vector and Vaccine Upstream (Raw Materials)
Table 22. Global Viral Vector and Vaccine Typical Customers
Table 23. Viral Vector and Vaccine Typical Distributors
Table 24. By Type, Global Viral Vector and Vaccine Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Viral Vector and Vaccine Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Viral Vector and Vaccine Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Viral Vector and Vaccine Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Viral Vector and Vaccine Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Viral Vector and Vaccine Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Viral Vector and Vaccine Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Viral Vector and Vaccine Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Viral Vector and Vaccine Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Viral Vector and Vaccine Sales Quantity Market Share, 2018-2029
Table 34. ABL Company Information, Head Office, Market Area, and Industry Position
Table 35. ABL Viral Vector and Vaccine Models, Specifications, and Application
Table 36. ABL Viral Vector and Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. ABL Company Profile and Main Business
Table 38. ABL Recent Developments
Table 39. Addgene Company Information, Head Office, Market Area, and Industry Position
Table 40. Addgene Viral Vector and Vaccine Models, Specifications, and Application
Table 41. Addgene Viral Vector and Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Addgene Company Profile and Main Business
Table 43. Addgene Recent Developments
Table 44. Aldevron Company Information, Head Office, Market Area, and Industry Position
Table 45. Aldevron Viral Vector and Vaccine Models, Specifications, and Application
Table 46. Aldevron Viral Vector and Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Aldevron Company Profile and Main Business
Table 48. Aldevron Recent Developments
Table 49. Boehringer Ingelheim International GmbH Company Information, Head Office, Market Area, and Industry Position
Table 50. Boehringer Ingelheim International GmbH Viral Vector and Vaccine Models, Specifications, and Application
Table 51. Boehringer Ingelheim International GmbH Viral Vector and Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Boehringer Ingelheim International GmbH Company Profile and Main Business
Table 53. Boehringer Ingelheim International GmbH Recent Developments
Table 54. Brammer Bio Company Information, Head Office, Market Area, and Industry Position
Table 55. Brammer Bio Viral Vector and Vaccine Models, Specifications, and Application
Table 56. Brammer Bio Viral Vector and Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Brammer Bio Company Profile and Main Business
Table 58. Brammer Bio Recent Developments
Table 59. Charles River Laboratories Company Information, Head Office, Market Area, and Industry Position
Table 60. Charles River Laboratories Viral Vector and Vaccine Models, Specifications, and Application
Table 61. Charles River Laboratories Viral Vector and Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Charles River Laboratories Company Profile and Main Business
Table 63. Charles River Laboratories Recent Developments
Table 64. Creative-Biogene Company Information, Head Office, Market Area, and Industry Position
Table 65. Creative-Biogene Viral Vector and Vaccine Models, Specifications, and Application
Table 66. Creative-Biogene Viral Vector and Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Creative-Biogene Company Profile and Main Business
Table 68. Creative-Biogene Recent Developments
Table 69. Fujifilm Corporation Company Information, Head Office, Market Area, and Industry Position
Table 70. Fujifilm Corporation Viral Vector and Vaccine Models, Specifications, and Application
Table 71. Fujifilm Corporation Viral Vector and Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Fujifilm Corporation Company Profile and Main Business
Table 73. Fujifilm Corporation Recent Developments
Table 74. General Electric Company Information, Head Office, Market Area, and Industry Position
Table 75. General Electric Viral Vector and Vaccine Models, Specifications, and Application
Table 76. General Electric Viral Vector and Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. General Electric Company Profile and Main Business
Table 78. General Electric Recent Developments
Table 79. MerckKGaA Company Information, Head Office, Market Area, and Industry Position
Table 80. MerckKGaA Viral Vector and Vaccine Models, Specifications, and Application
Table 81. MerckKGaA Viral Vector and Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. MerckKGaA Company Profile and Main Business
Table 83. MerckKGaA Recent Developments
Table 84. Novasep Company Information, Head Office, Market Area, and Industry Position
Table 85. Novasep Viral Vector and Vaccine Models, Specifications, and Application
Table 86. Novasep Viral Vector and Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Novasep Company Profile and Main Business
Table 88. Novasep Recent Developments
Table 89. Pfizer Company Information, Head Office, Market Area, and Industry Position
Table 90. Pfizer Viral Vector and Vaccine Models, Specifications, and Application
Table 91. Pfizer Viral Vector and Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Pfizer Company Profile and Main Business
Table 93. Pfizer Recent Developments
Table 94. Spark Therapeutics Company Information, Head Office, Market Area, and Industry Position
Table 95. Spark Therapeutics Viral Vector and Vaccine Models, Specifications, and Application
Table 96. Spark Therapeutics Viral Vector and Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Spark Therapeutics Company Profile and Main Business
Table 98. Spark Therapeutics Recent Developments
Table 99. Thermo Fisher Scientific Company Information, Head Office, Market Area, and Industry Position
Table 100. Thermo Fisher Scientific Viral Vector and Vaccine Models, Specifications, and Application
Table 101. Thermo Fisher Scientific Viral Vector and Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Thermo Fisher Scientific Company Profile and Main Business
Table 103. Thermo Fisher Scientific Recent Developments
Table 104. Waisman Biomanufacturing Company Information, Head Office, Market Area, and Industry Position
Table 105. Waisman Biomanufacturing Viral Vector and Vaccine Models, Specifications, and Application
Table 106. Waisman Biomanufacturing Viral Vector and Vaccine Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. Waisman Biomanufacturing Company Profile and Main Business
Table 108. Waisman Biomanufacturing Recent Developments
List of Figures
Figure 1. Viral Vector and Vaccine Picture
Figure 2. Global Viral Vector and Vaccine Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Viral Vector and Vaccine Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global Viral Vector and Vaccine Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Viral Vector and Vaccine Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Viral Vector and Vaccine Sales Quantity (K Units) & (2018-2029)
Figure 7. China Viral Vector and Vaccine Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Viral Vector and Vaccine Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Viral Vector and Vaccine Market Share of Global, 2018-2029
Figure 10. Global Viral Vector and Vaccine Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Viral Vector and Vaccine Key Participants, Market Share, 2022
Figure 12. Global Viral Vector and Vaccine Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Viral Vector and Vaccine Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Viral Vector and Vaccine Production Market Share & Forecast by Region, 2018-2029
Figure 15. Viral Vector and Vaccine Industry Chain
Figure 16. Viral Vector and Vaccine Procurement Model
Figure 17. Viral Vector and Vaccine Sales Model
Figure 18. Viral Vector and Vaccine Sales Channels, Direct Sales, and Distribution
Figure 19. Adenovirus
Figure 20. Fowlpox Virus
Figure 21. Attenuated Yellow Fever
Figure 22. Vaccinia Virus Vectors
Figure 23. By Type, Global Viral Vector and Vaccine Consumption Value, 2018-2029, US$ Million
Figure 24. By Type, Global Viral Vector and Vaccine Consumption Value Market Share, 2018-2029
Figure 25. By Type, Global Viral Vector and Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 26. By Type, Global Viral Vector and Vaccine Sales Quantity Market Share, 2018-2029
Figure 27. By Type, Global Viral Vector and Vaccine Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 28. Research Institutes
Figure 29. Biopharmaceutical Companies
Figure 30. Others
Figure 31. By Application, Global Viral Vector and Vaccine Consumption Value, 2018-2029, US$ Million
Figure 32. By Application, Global Viral Vector and Vaccine Consumption Value Market Share, 2018-2029
Figure 33. By Application, Global Viral Vector and Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 34. By Application, Global Viral Vector and Vaccine Sales Quantity Market Share, 2018-2029
Figure 35. By Application, Global Viral Vector and Vaccine Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 36. By Region, Global Viral Vector and Vaccine Consumption Value Market Share, 2018-2029
Figure 37. By Region, Global Viral Vector and Vaccine Sales Quantity Market Share, 2018-2029
Figure 38. North America Viral Vector and Vaccine Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 39. By Country, North America Viral Vector and Vaccine Consumption Value Market Share, 2022
Figure 40. Europe Viral Vector and Vaccine Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 41. By Country, Europe Viral Vector and Vaccine Consumption Value Market Share, 2022
Figure 42. Asia Pacific Viral Vector and Vaccine Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 43. By Country/Region, Asia Pacific Viral Vector and Vaccine Consumption Value Market Share, 2022
Figure 44. South America Viral Vector and Vaccine Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 45. By Country, South America Viral Vector and Vaccine Consumption Value Market Share, 2022
Figure 46. Middle East & Africa Viral Vector and Vaccine Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 47. U.S. Viral Vector and Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 48. By Type, U.S. Viral Vector and Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 49. By Application, U.S. Viral Vector and Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 50. Europe Viral Vector and Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 51. By Type, Europe Viral Vector and Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 52. By Application, Europe Viral Vector and Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 53. China Viral Vector and Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 54. By Type, China Viral Vector and Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 55. By Application, China Viral Vector and Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 56. Japan Viral Vector and Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 57. By Type, Japan Viral Vector and Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 58. By Application, Japan Viral Vector and Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 59. South Korea Viral Vector and Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 60. By Type, South Korea Viral Vector and Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 61. By Application, South Korea Viral Vector and Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 62. Southeast Asia Viral Vector and Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 63. By Type, Southeast Asia Viral Vector and Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 64. By Application, Southeast Asia Viral Vector and Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 65. India Viral Vector and Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 66. By Type, India Viral Vector and Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 67. By Application, India Viral Vector and Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 68. Middle East & Africa Viral Vector and Vaccine Sales Quantity, 2018-2029, (K Units)
Figure 69. By Type, Middle East & Africa Viral Vector and Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 70. By Application, Middle East & Africa Viral Vector and Vaccine Sales Quantity Market Share, 2022 VS 2029
Figure 71. Research Methodology
Figure 72. Breakdown of Primary Interviews
Figure 73. Bottom-up and Top-down Approaches
Figure 74. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|